Biotech grants in the United States
Explore Biotech grants for companies in the United States. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from US innovation agencies, research funders and foundations, international programs open to applicants in the United States, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in the United States come first.
Showing 169-192 of 1,239 grants
NIH Small Business Technology Transfer Grant
🇺🇸NIH · United States
Funds early feasibility work through late-stage R&D for a US small business formally partnered with a nonprofit research institution.
NIH, CDC and FDA Small Business Innovation Research Grant
🇺🇸NIH · United States
Funds early feasibility work through late-stage R&D for a US small business turning a health science idea into a marketable product.
Computational Approaches to Curation at Scale for Biomedical Research Assets
🇺🇸NIH · United States
Funds computational methods that curate biomedical data at scale, so datasets and models become usable faster than hand-curation allows.
NHLBI Emerging Investigator Award (EIA)
🇺🇸NIH · United States
Funds a heart, lung, blood or sleep researcher's whole programme for up to seven years, replacing the institute grants they hold today.
NHLBI Outstanding Investigator Award (OIA)
🇺🇸NIH · United States
Funds an established heart, lung, blood or sleep researcher's whole programme for up to seven years, replacing the grants they hold today.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33)
🇺🇸NIH · United States
Funds mechanistic work on the host biology that decides who responds to a probiotic and who does not.
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33)
🇺🇸NIH · United States
Funds two years finding the host biology behind inconsistent probiotic responses, then more to test whether those patterns actually predict who responds.
NIGMS National and Regional Resources
🇺🇸NIH · United States
Funds equipment, tools, or services that a shared resource offers biomedical researchers across a region or the country.
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience
🇺🇸NIH · United States
Funds a minority-serving or IDeA-eligible institution to build a facility that makes and ships brain cell-targeting reagents to neuroscience labs.
Brain Behavior Quantification and Synchronization — Next Gen Sensor Technology Development
🇺🇸BRAIN Initiative · United States
Supports neural behavior-sensing technology development through translational cooperative projects.
NICHD Resource Program Grants in Bioinformatics
🇺🇸NIH · United States
Funds the continued operation of a bioinformatics database that the animal-model developmental biology community depends on.
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
🇺🇸MRDC / CDMRP · United States
Funds an unsolicited medical research idea across USAMRDC's whole portfolio, but only after a pre-proposal through eBRAP earns an invitation to submit in full.
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders
🇺🇸NIH · United States
Funds IND-enabling studies and planning that take a gene-based therapy for an ultra-rare neurological or neuromuscular disorder toward its first human trial.
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders
🇺🇸NIH · United States
Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award
🇺🇸NIH · United States
Funds collaborative projects that build, test and spread new tools or methods across NIH's national network of clinical and translational research hubs.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01)
🇺🇸NIH · United States
Funds one investigator's discovery-to-proof-of-concept project on a new drug, ligand or neurostimulation device for a mental or substance use disorder.
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19)
🇺🇸NIH · United States
Funds a coordinated multi-project program discovering and testing new drugs, ligands or neurostimulation devices for mental or substance use disorders.
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards
🇺🇸NIH · United States
Funds the renewal of a neurology clinical trial the institute already supports, where finishing it needs more time and resources.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
Toward Translation of Nanotechnology Cancer Interventions (TTNCI)
🇺🇸NIH · United States
Funds advanced preclinical work maturing a nanoparticle-based cancer diagnostic or therapeutic toward the National Cancer Institute's own translation pipeline.
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases
🇺🇸NIH · United States
Funds basic biochemical or biological work on a protein from a published list — druggable, linked to a rare disease, and barely studied.
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK
🇺🇸NIH · United States
Funds pilot basic and translational work on HIV complications in the organs and processes the diabetes, digestive and kidney institute covers.
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
🇺🇸NIH · United States
Funds basic research on the harm caused by a single exposure to ultra-potent synthetic opioids, including the effects that appear later.